{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T04:49:15Z","timestamp":1763786955424,"version":"3.45.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"This work was supported by the National Natural Science Foundation Project of China","award":["(No. 81973743)","(No. 81973743)"],"award-info":[{"award-number":["(No. 81973743)","(No. 81973743)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Histol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10735-025-10622-0","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T16:02:59Z","timestamp":1760457779000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Zhuyu pill mitigates NAFLD through activation of IL22\/JAK1\/STAT3 signaling pathway"],"prefix":"10.1007","volume":"56","author":[{"given":"Tong","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaobo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zubing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,14]]},"reference":[{"issue":"2","key":"10622_CR1","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1002\/hep.31046","volume":"72","author":"JP Arab","year":"2020","unstructured":"Arab JP, Sehrawat TS, Simonetto DA et al (2020) An open-label, dose-escalation study to assess the safety and efficacy of IL-22 agonist F-652 in patients with alcohol-associated hepatitis. Hepatology 72(2):441\u2013453","journal-title":"Hepatology"},{"issue":"1","key":"10622_CR2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ajpath.2012.08.043","volume":"182","author":"MA Cobleigh","year":"2013","unstructured":"Cobleigh MA, Robek MD (2013) Protective and pathological properties of IL-22 in liver disease: implications for viral hepatitis. Am J Pathol 182(1):21\u201328","journal-title":"Am J Pathol"},{"key":"10622_CR3","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1146\/annurev-immunol-032414-112123","volume":"33","author":"JA Dudakov","year":"2015","unstructured":"Dudakov JA, Hanash AM, van den Brink MR (2015) Interleukin-22: immunobiology and pathology. Annu Rev Immunol 33:747\u2013785","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"10622_CR4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ajg.2014.01.009","volume":"15","author":"H El Bassat","year":"2014","unstructured":"El Bassat H, Ziada DH, Hasby EA, Nagy H, Abo Ryia MH (2014) Apoptotic and anti-apoptotic seromarkers for assessment of disease severity of non-alcoholic steatohepatitis. Arab J Gastroenterol 15(1):6\u201311","journal-title":"Arab J Gastroenterol"},{"issue":"7","key":"10622_CR5","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"SL Friedman","year":"2018","unstructured":"Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ (2018) Mechanisms of NAFLD development and therapeutic strategies. Nat Med 24(7):908\u2013922","journal-title":"Nat Med"},{"issue":"5","key":"10622_CR6","doi-asserted-by":"publisher","first-page":"E405","DOI":"10.1152\/ajpendo.00150.2022","volume":"323","author":"Z Gao","year":"2022","unstructured":"Gao Z, Wang G, Ma X et al (2022) Troxerutin attenuates insulin resistance via pancreatic IL-22\/JAK1\/STAT3 signaling activation in dihydrotestosterone-induced polycystic ovary syndrome rats. Am J Physiol Endocrinol Metab 323(5):E405\u2013E417","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"Pt B","key":"10622_CR7","doi-asserted-by":"publisher","first-page":"116927","DOI":"10.1016\/j.jep.2023.116927","volume":"318","author":"P Gong","year":"2024","unstructured":"Gong P, Long H, Guo Y et al (2024) Chinese herbal medicines: the modulator of nonalcoholic fatty liver disease targeting oxidative stress. J Ethnopharmacol 318(Pt B):116927","journal-title":"J Ethnopharmacol"},{"key":"10622_CR8","doi-asserted-by":"publisher","first-page":"1280864","DOI":"10.3389\/fphar.2023.1280864","volume":"14","author":"J Han","year":"2023","unstructured":"Han J, Wu P, Wen Y et al (2023) The zhuyu pill relieves rat cholestasis by regulating the mRNA expression of lipid and bile metabolism associated genes. Front Pharmacol 14:1280864","journal-title":"Front Pharmacol"},{"issue":"25","key":"10622_CR9","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.3748\/wjg.v24.i25.2661","volume":"24","author":"T Kanda","year":"2018","unstructured":"Kanda T, Matsuoka S, Yamazaki M et al (2018) Apoptosis and non-alcoholic fatty liver diseases. World J Gastroenterol 24(25):2661\u20132672","journal-title":"World J Gastroenterol"},{"issue":"8","key":"10622_CR10","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.3390\/ijms19082299","volume":"19","author":"MM Kasembeli","year":"2018","unstructured":"Kasembeli MM, Bharadwaj U, Robinson P, Tweardy DJ (2018) Contribution of STAT3 to inflammatory and fibrotic diseases and prospects for its targeting for treatment. Int J Mol Sci 19(8):2299","journal-title":"Int J Mol Sci"},{"key":"10622_CR11","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/jgh.12032","volume":"28","author":"X Kong","year":"2013","unstructured":"Kong X, Feng D, Mathews S, Gao B (2013) Hepatoprotective and anti-fibrotic functions of interleukin-22: therapeutic potential for the treatment of alcoholic liver disease. J Gastroenterol Hepatol 28:56\u201360","journal-title":"J Gastroenterol Hepatol"},{"issue":"9","key":"10622_CR12","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/nrm909","volume":"3","author":"DE Levy","year":"2002","unstructured":"Levy DE, Darnell JE Jr (2002) Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol 3(9):651\u2013662","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"10622_CR13","doi-asserted-by":"publisher","first-page":"3991","DOI":"10.4238\/2014.May.23.10","volume":"13","author":"CP Li","year":"2014","unstructured":"Li CP, Li JH, He SY, Li P, Zhong XL (2014) Roles of Fas\/Fasl, Bcl-2\/Bax, and Caspase-8 in rat nonalcoholic fatty liver disease pathogenesis. Genet Mol Res 13(2):3991\u20133999","journal-title":"Genet Mol Res"},{"issue":"15","key":"10622_CR14","doi-asserted-by":"publisher","first-page":"8255","DOI":"10.1093\/nar\/gkaa615","volume":"48","author":"X Li","year":"2020","unstructured":"Li X, Wang J, Gong X et al (2020) Upregulation of BCL-2 by acridone derivative through gene promoter i-motif for alleviating liver damage of NAFLD\/NASH. Nucleic Acids Res 48(15):8255\u20138268","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"10622_CR15","first-page":"39","volume":"28","author":"YY Li","year":"2022","unstructured":"Li YY, Huang NT, Han FM et al (2022) Analysis of Zuojinwan based on ancient literature. Chin J Exp Tradit Med Formulae 28(12):39\u201347","journal-title":"Chin J Exp Tradit Med Formulae"},{"issue":"8","key":"10622_CR16","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1055\/s-0029-1240701","volume":"76","author":"Y Luo","year":"2010","unstructured":"Luo Y, Zhao H, Liu Z et al (2010) Comparison of the enteric mucosal immunomodulatory activity of combinations of Coptis chinensis Franch. Rhizomes and Evodia rutaecarpa (Juss.) Benth. Fruits in mice with dextran sulphate sodium-induced ulcerative colitis. Planta Med 76(8):766\u2013772","journal-title":"Planta Med"},{"issue":"17","key":"10622_CR17","doi-asserted-by":"publisher","first-page":"12093","DOI":"10.1074\/jbc.M510660200","volume":"281","author":"H Malhi","year":"2006","unstructured":"Malhi H, Bronk SF, Werneburg NW, Gores GJ (2006) Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis. J Biol Chem 281(17):12093\u201312101","journal-title":"J Biol Chem"},{"key":"10622_CR18","doi-asserted-by":"publisher","first-page":"155909","DOI":"10.1016\/j.phymed.2024.155909","volume":"133","author":"G Meng","year":"2024","unstructured":"Meng G, Li P, Du X, Feng X, Qiu F (2024) Berberine alleviates ulcerative colitis by inhibiting inflammation through targeting IRGM1. Phytomedicine 133:155909","journal-title":"Phytomedicine"},{"issue":"15","key":"10622_CR19","doi-asserted-by":"publisher","first-page":"4170","DOI":"10.7150\/thno.25798","volume":"8","author":"R Mo","year":"2018","unstructured":"Mo R, Lai R, Lu J et al (2018) Enhanced autophagy contributes to protective effects of IL-22 against acetaminophen-induced liver injury. Theranostics 8(15):4170\u20134180","journal-title":"Theranostics"},{"issue":"10","key":"10622_CR20","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1002\/oby.22964","volume":"28","author":"MP Moore","year":"2020","unstructured":"Moore MP, Cunningham RP, Dashek RJ, Mucinski JM, Rector RS (2020) A fad too far? Dietary strategies for the prevention and treatment of NAFLD. Obesity 28(10):1843\u20131852","journal-title":"Obesity"},{"key":"10622_CR21","first-page":"802","volume-title":"Pharmacopoeia of the People\u2019s Republic of China","author":"National Pharmacopoeia Commission","year":"2020","unstructured":"National Pharmacopoeia Commission (2020) Pharmacopoeia of the People\u2019s Republic of China, 2020th edn. China Medical Science Press, Beijing, p 802","edition":"2020"},{"issue":"1","key":"10622_CR22","first-page":"43","volume":"1","author":"H Pan","year":"2004","unstructured":"Pan H, Hong F, Radaeva S, Gao B (2004) Hydrodynamic gene delivery of interleukin-22 protects the mouse liver from concanavalin A-, carbon tetrachloride-, and Fas ligand-induced injury via activation of STAT3. Cell Mol Immunol 1(1):43\u201349","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"10622_CR23","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1002\/hep.24339","volume":"54","author":"O Park","year":"2011","unstructured":"Park O, Wang H, Weng H et al (2011) In vivo consequences of liver-specific interleukin-22 expression in mice: implications for human liver disease progression. Hepatology 54(1):252\u2013261","journal-title":"Hepatology"},{"key":"10622_CR24","doi-asserted-by":"publisher","first-page":"603926","DOI":"10.3389\/fphar.2020.603926","volume":"11","author":"C Peng","year":"2020","unstructured":"Peng C, Stewart AG, Woodman OL, Ritchie RH, Qin CX (2020) Non-alcoholic steatohepatitis: a review of its mechanism, models and medical treatments. Front Pharmacol 11:603926","journal-title":"Front Pharmacol"},{"issue":"1","key":"10622_CR25","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/00042737-200601000-00005","volume":"18","author":"RM Ramalho","year":"2006","unstructured":"Ramalho RM, Cortez-Pinto H, Castro RE et al (2006) Apoptosis and Bcl-2 expression in the livers of patients with steatohepatitis. Eur J Gastroenterol Hepatol 18(1):21\u201329","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"9","key":"10622_CR26","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1111\/j.1572-0241.2004.40009.x","volume":"99","author":"PS Ribeiro","year":"2004","unstructured":"Ribeiro PS, Cortez-Pinto H, Sol\u00e1 S et al (2004) Hepatocyte apoptosis, expression of death receptors, and activation of NF-kappaB in the liver of nonalcoholic and alcoholic steatohepatitis patients. Am J Gastroenterol 99(9):1708\u20131717","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10622_CR27","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.jhep.2017.05.016","volume":"67","author":"M Romero-G\u00f3mez","year":"2017","unstructured":"Romero-G\u00f3mez M, Zelber-Sagi S, Trenell M (2017) Treatment of NAFLD with diet, physical activity and exercise. J Hepatol 67(4):829\u2013846","journal-title":"J Hepatol"},{"issue":"10","key":"10622_CR28","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1111\/liv.15024","volume":"41","author":"G Semmler","year":"2021","unstructured":"Semmler G, Datz C, Reiberger T, Trauner M (2021) Diet and exercise in NAFLD\/NASH: beyond the obvious. Liver Int 41(10):2249\u20132268","journal-title":"Liver Int"},{"issue":"12","key":"10622_CR29","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.autrev.2017.10.004","volume":"16","author":"AG Shabgah","year":"2017","unstructured":"Shabgah AG, Navashenaq JG, Shabgah OG, Mohammadi H, Sahebkar A (2017) Interleukin-22 in human inflammatory diseases and viral infections. Autoimmun Rev 16(12):1209\u20131218","journal-title":"Autoimmun Rev"},{"issue":"7521","key":"10622_CR30","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature13564","volume":"514","author":"X Wang","year":"2014","unstructured":"Wang X, Ota N, Manzanillo P et al (2014) Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetes. Nature 514(7521):237\u2013241","journal-title":"Nature"},{"issue":"5","key":"10622_CR31","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1210\/er.2019-00034","volume":"40","author":"MJ Watt","year":"2019","unstructured":"Watt MJ, Miotto PM, De Nardo W, Montgomery MK (2019) The liver as an endocrine organ-linking NAFLD and insulin resistance. Endocr Rev 40(5):1367\u20131393","journal-title":"Endocr Rev"},{"issue":"13","key":"10622_CR32","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.7150\/ijbs.38925","volume":"16","author":"Y Wu","year":"2020","unstructured":"Wu Y, Min J, Ge C et al (2020) Interleukin 22 in liver injury, inflammation and cancer. Int J Biol Sci 16(13):2405\u20132413","journal-title":"Int J Biol Sci"},{"issue":"8","key":"10622_CR33","doi-asserted-by":"publisher","first-page":"e0134172","DOI":"10.1371\/journal.pone.0134172","volume":"10","author":"HM Yan","year":"2015","unstructured":"Yan HM, Xia MF, Wang Y, Chang XX, Yao XZ, Rao SX, Zeng MS, Tu YF, Feng R, Jia WP, Liu J, Deng W, Jiang JD, Gao X (2015) Efficacy of Berberine in Patients with Non-Alcoholic Fatty Liver Disease. PLoS ONE 10(8):e0134172","journal-title":"PLoS ONE"},{"key":"10622_CR34","doi-asserted-by":"publisher","first-page":"115405","DOI":"10.1016\/j.jep.2022.115405","volume":"296","author":"X Zhang","year":"2022","unstructured":"Zhang X, Gao R, Zhou Z, Sun J, Tang X, Li J, Zhou X, Shen T (2022) Uncovering the mechanism of Huanglian-Wuzhuyu herb pair in treating nonalcoholic steatohepatitis based on network pharmacology and experimental validation. J Ethnopharmacol 296:115405","journal-title":"J Ethnopharmacol"},{"key":"10622_CR35","volume-title":"Danxi\u2019s mastery of medicine","author":"DX Zhu","year":"2012","unstructured":"Zhu DX (2012) Danxi\u2019s mastery of medicine. China Medical Science Press, Beijing"},{"issue":"12","key":"10622_CR36","doi-asserted-by":"publisher","first-page":"6298","DOI":"10.1039\/C8FO01227J","volume":"9","author":"J Zhu","year":"2018","unstructured":"Zhu J, Zhou M, Zhao X, Mu M, Cheng M (2018) Blueberry, combined with probiotics, alleviates non-alcoholic fatty liver disease via IL-22-mediated JAK1\/STAT3\/BAX signaling. Food Funct 9(12):6298\u20136306","journal-title":"Food Funct"}],"container-title":["Journal of Molecular Histology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-025-10622-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10735-025-10622-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-025-10622-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T04:46:39Z","timestamp":1763786799000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10735-025-10622-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,14]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10622"],"URL":"https:\/\/doi.org\/10.1007\/s10735-025-10622-0","relation":{},"ISSN":["1567-2379","1567-2387"],"issn-type":[{"type":"print","value":"1567-2379"},{"type":"electronic","value":"1567-2387"}],"subject":[],"published":{"date-parts":[[2025,10,14]]},"assertion":[{"value":"11 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}],"article-number":"341"}}